Wednesday, 14 September 2022

Novartis invest USD 300m to develop biotherapeutics portfolio

Novartis invest USD 300m to develop biotherapeutics portfolio
Novartis invest USD 300m to develop biotherapeutics portfolio

Novartis announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will bolster its capacity and capabilities for early technical development of biologics. Spanning both drug substance and drug product development, the multi-year investment will be implemented across existing Novartis locations in Switzerland, Slovenia and Austria, strengthening Novartis ability to deliver on the increasing growth and diversity of its early-stage biotherapeutics portfolio.

Pradip Mahajan Wed, 09/14/2022 - 16:17

source https://www.pharmatutor.org/pharma-news/2022/novartis-invest-usd-300m-to-develop-biotherapeutics-portfolio

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...